Literature DB >> 25755531

Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.

Sundeep K Goyal1, Vinod K Dixit1, Ashok K Jain1, Pradeep K Mohapatra1, Jayant K Ghosh1.   

Abstract

BACKGROUND: Traditionally, Maddrey discriminant function (DF) score has been used for stratifying the prognosis of alcoholic hepatitis. Recently, the Model for end-stage liver disease (MELD) score has been applied to alcoholic hepatitis and some investigators consider MELD score as a better prognostic indicator. Another new prognostic approach, Lille model has been also suggested to accurately identify patients at high risk of death. Therefore, this prospective study was aimed to compare MELD, DF, Child-Turcotte-Pugh (CTP) scores and Lille model for predicting the short-term mortality in Indian patients with alcoholic hepatitis.
METHODS: We calculated the DF, CTP, MELD and Lille scores in patients hospitalized with alcoholic hepatitis & evaluated if the scores predicted in-hospital mortality.
RESULTS: A total of 104 patients were enrolled and thirty-two (30.7%) patients died during the hospitalization (2-30 days). Admission DF score (OR 1.1, P < 0.04), CTP (OR 2, P < 0.05) MELD score (OR 2.2, P < 0.005) and first week MELD score (OR 1.1, P < 0.05) were independently associated with in-hospital mortality. The area under the receiver-operating curve (AUROC) for the admission and day 7 MELD score was significantly higher than CTP score and was comparable to DF score and Lille model (AUC &amp; 95% CI: 0.97 [0.95-1.0], 0.99 [0.99-1.0], 0.91 [0.83-0.91] and 0.92 [0.86-0.98] for MELD at admission &amp; day 7, admission DF and Lille model, respectively). The MELD score >14 at admission and >12 at day 7 had high sensitivity and specificity in predicting short-term mortality (96%, 89% and 95%, 98% respectively). The cutoff of 0.45 for the Lille model was able to identify 79% of the observed deaths, whereas DF score ≥32 for DF were able to identify 85%.
CONCLUSION: MELD score, as a predictive model for assessment of short-term mortality in alcoholic hepatitis is better than CTP and comparable to DF and Lille model.

Entities:  

Keywords:  AH, alcoholic hepatitis; AUC, area under the curve; AUROC, area under the receiver-operating curve; CTP; CTP, Child–Turcotte–Pugh score; DF; HCC, hepatocellular carcinoma; HRS, hepatorenal syndrome; MELD; MELD, Model for end-stage liver disease; PVT, portal vein thrombosis; SBP, spontaneous bacterial peritonitis; alcoholic hepatitis

Year:  2014        PMID: 25755531      PMCID: PMC4017178          DOI: 10.1016/j.jceh.2014.02.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression.

Authors:  R Kumashiro; M Sata; K Ishii; Y Koga; S Furudera; J Seo; N Kusaba; M Sakai; N Ikejiri; K Tanikawa
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

4.  Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.

Authors:  H P Porter; F R Simon; C E Pope; W Volwiler; L F Fenster
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

5.  MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.

Authors:  Wichit Srikureja; Namgyal L Kyulo; Bruce A Runyon; Ke-Qin Hu
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

6.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

Authors:  M J Ramond; T Poynard; B Rueff; P Mathurin; C Théodore; J C Chaput; J P Benhamou
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

9.  The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Authors:  Alexandre Louvet; Sylvie Naveau; Marcelle Abdelnour; Marie-José Ramond; Emmanuel Diaz; Laetitia Fartoux; Sébastien Dharancy; Frédéric Texier; Antoine Hollebecque; Lawrence Serfaty; Emmanuel Boleslawski; Pierre Deltenre; Valérie Canva; François-René Pruvot; Philippe Mathurin
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

10.  Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.

Authors:  R L Carithers; H F Herlong; A M Diehl; E W Shaw; B Combes; H J Fallon; W C Maddrey
Journal:  Ann Intern Med       Date:  1989-05-01       Impact factor: 25.391

View more
  6 in total

1.  Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.

Authors:  Ravi Daswani; Ashish Kumar; Shrihari Anil Anikhindi; Praveen Sharma; Vikas Singla; Naresh Bansal; Anil Arora
Journal:  Indian J Gastroenterol       Date:  2018-04-28

2.  Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification.

Authors:  Ryan E Owens; Heather S Snyder; Jennifer D Twilla; Sanjaya K Satapathy
Journal:  J Clin Exp Hepatol       Date:  2016-07-18

3.  Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.

Authors:  Augustin G L Vannier; Vladislav Fomin; Raymond T Chung; Suraj J Patel; Esperance Schaefer; Russell P Goodman; Jay Luther
Journal:  Gastro Hep Adv       Date:  2022-03-30

4.  The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

Authors:  D Morales-Arráez; M Ventura-Cots; J Altamirano; J G Abraldes; M Cruz-Lemini; M R Thursz; S R Atkinson; S K Sarin; W Kim; R Chavez-Araujo; M F Higuera-de la Tijera; A K Singal; V H Shah; P S Kamath; A Duarte-Rojo; E A Charles; V Vargas; M Jager; P E Rautou; D Rincon; F Zamarripa; J C Restrepo-Gutiérrez; A Torre; M R Lucey; J P Arab; P Mathurin; A Louvet; G García-Tsao; J A González; E C Verna; R S Brown; J Argemi; C Fernández-Carrillo; A Clemente; E Alvarado-Tapias; E Forrest; M Allison; R Bataller
Journal:  Am J Gastroenterol       Date:  2022-02-01       Impact factor: 12.045

5.  Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.

Authors:  Augustin G L Vannier; Jessica E S Shay; Vladislav Fomin; Suraj J Patel; Esperance Schaefer; Russell P Goodman; Jay Luther
Journal:  JAMA Netw Open       Date:  2022-05-02

6.  Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.

Authors:  Hee Yeon Kim; Chang Wook Kim; Tae Yeob Kim; Do Seon Song; Dong Hyun Sinn; Eileen L Yoon; Young Kul Jung; Ki Tae Suk; Sang Soo Lee; Chang Hyeong Lee; Tae Hun Kim; Jeong Han Kim; Hyung Joon Yim; Sung Eun Kim; Soon Koo Baik; Byung Seok Lee; Jae Young Jang; Young Seok Kim; Sang Gyune Kim; Jin Mo Yang; Joo Hyun Sohn; Heon Ju Lee; Seung Ha Park; Eun Hee Choi; Dong Joon Kim
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.